Sunday, November 12, 2023

Global Gelfoam Market Research Report 2023

What is Global Gelfoam Market?

The Global Gelfoam Market is a fascinating sector of the healthcare industry that focuses on the production and distribution of Gelfoam, a surgical dressing made from purified pork skin gelatin. This product is used in various surgical procedures to control bleeding, and its market has been growing steadily over the years. The Gelfoam Market is a global entity, with its products being used in hospitals, clinics, and healthcare facilities all over the world. The market is segmented into different types of Gelfoam products, such as sponge and powder-based Gelfoam. Each type has its unique properties and uses, making them suitable for different surgical procedures. The sponge-based Gelfoam is a soft, pliable, and absorbent material that can be cut to any size or shape, making it ideal for use in various surgical procedures. On the other hand, the powder-based Gelfoam is a fine, granular material that can be sprinkled onto a bleeding surface to control bleeding. Both types of Gelfoam are sterile, absorbable, and safe to use, making them a popular choice among surgeons and healthcare professionals.

Gelfoam Market

Sponge, Powder in the Global Gelfoam Market:

The Global Gelfoam Market is not just about the production and distribution of Gelfoam products. It also involves the use of these products in various surgical procedures. Gelfoam is used in minimally invasive surgery, general surgery, and other types of surgery. In minimally invasive surgery, Gelfoam is used to control bleeding and facilitate the healing process. It is inserted into the surgical site through a small incision, where it absorbs blood and forms a gelatinous mass that aids in clotting. In general surgery, Gelfoam is used to control bleeding in larger surgical sites. It is applied directly to the bleeding surface, where it absorbs blood and forms a gelatinous mass that aids in clotting. In other types of surgery, Gelfoam is used in a similar manner to control bleeding and facilitate the healing process. The use of Gelfoam in these various surgical procedures has contributed significantly to the growth of the Global Gelfoam Market.

Minimally Invasive Surgery, General Surgery, Others in the Global Gelfoam Market:

The Global Gelfoam Market is a dynamic and evolving sector of the healthcare industry. As per the market outlook, the market was valued at US$ 916.3 million in 2022 and is expected to reach US$ 1260 million by 2029, growing at a CAGR of 4.6% during the forecast period 2023-2029. The largest proportion of Gelfoam, about 44%, is used for general surgery. North America is the largest consumer of Gelfoam, accounting for nearly 42% of the global consumption. The market is dominated by several key players, including Johnson & Johnson, Gelita, Pfizer, Baxter, Ferrosan Medical Devices, B Braun, and Equimedical, who collectively hold about 92% of the market shares. These figures highlight the significant growth potential of the Global Gelfoam Market and its importance in the healthcare industry.


Report Metric Details
Report Name Gelfoam Market
Accounted market size in 2022 US$ 916.3 million
Forecasted market size in 2029 US$ 1260 million
CAGR 4.6%
Base Year 2022
Forecasted years 2023 - 2029
Segment by Type
  • Sponge
  • Powder
Segment by Application
  • Minimally Invasive Surgery
  • General Surgery
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Johnson & Johnson, Gelita, Pfizer, Baxter, Ferrosan Medical Devices, B Braun, Equimedical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Global Non-Insulin Peptide Drug Market Research Report 2025

What is Global Non-Insulin Peptide Drug Market? The Global Non-Insulin Peptide Drug Market is a rapidly evolving sector within the pharmace...